Skip to Content

827 (Tamoxifen Citrate 20 mg)

Pill with imprint 827 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, male; breast cancer, metastatic; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 827

Tamoxifen citrate 20 mg 827

Tamoxifen Citrate

Imprint
827
Strength
20 mg
Color
White
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Hormones/antineoplastics, Selective estrogen receptor modulators
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0827
Inactive Ingredients
carboxymethylcellulose calcium, hypromelloses, magnesium stearate, mannitol, polyethylene glycol, corn starch, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "827"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.